Login
Navigate Fool.com
Will BCRX beat
the market?
Community Rating: 1 Star: Ominous

11.66 0.39 (3.46%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $11.34
Previous Close $11.27
Daily Range $11.21 - $11.75
52-Week Range $2.83 - $13.33
Market Cap $700.4M
P/E Ratio -17.89
Dividend (Yield) $0.00 (0.0%)
Volume 651,597
Average Daily Volume 1,366,440
Current FY EPS -$0.72

How do you think BCRX
will perform against the market?

Top BCRX Bull/Bear Pitches

 

TMFBiologyFool (< 20)
Submitted March 9, 2011

Will rise during next pandemic flu. When will that happen? I have no idea, but at this cheap price, it's not that hard to wait.

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted April 1, 2013

As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this: BioCryst Pharmaceuticals, Inc. t … More

3 Replies Reply Report this Post

News & Commentary Rss Feed

This Week in Biotech: VIVUS Attracts Buyout Interest While BioCryst Wows Investors

One mega-merger falls through the cracks, another struggling biotech draws buyout interest, and three biotechs deliver impressive clinical results.

Use Options For a Chance To Buy BCRX at a 58% Discount

Top Analyst Upgrades and Downgrades: AMD, Dish Network, Facebook, Nordstrom, SunPower and More

After Idenix: The Next Four Biotech Buyout Candidates

3 Reasons Shire Could Keep Soaring

Shire has had a great run over the past 12 months, and it could continue soaring thanks to these three key strengths.

Better Buy: BioCryst vs. Dyax

Both rose on great news yesterday. Which is the better buy?

Why Dyax, Hillshire Brands, and Aeropostale Are Today's 3 Best Stocks

A trio of positive economic data sends the S&P 500 to a fresh all-time high while Dyax, Hillshire Brands, and Aeropostale all surge by 15% or more.

Mid-Afternoon Market Update: S&P Looks To Close At All-Time High As Analogic Takes A Hit On Prelimin

Mid-Afternoon Market Update: S&P Looks To Close At All-Time High As Analogic Takes A Hit On Preliminary Results

Why BioCryst Pharmaceuticals Inc. Shares Soared

BioCryst shares soar after delivering upbeat data from its rare-disease proof-of-concept study. Find out if shares can head even higher.

Mid-Day Market Update: Analogic Tumbles On Weak Outlook; BioCryst Shares Gain

See More BCRX News...

Sector

Healthcare

Industry

Drugs

BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website: http://www.biocryst.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks